American Portfolios Advisors’s Adamas Pharmaceuticals ADMS Stock Holding History

American Portfolios Advisors’s Portfolio ADMS Stock Details ADMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-150	Closed	-$737	–	3637
2021 Q3	$737	Hold	150	–	–	﹤0.01%	3351
2021 Q2	$792	Hold	150	–	–	﹤0.01%	3286
2021 Q1	$720	Hold	150	–	–	﹤0.01%	3172
2020 Q4	$650	Hold	150	–	–	﹤0.01%	2885
2020 Q3	$618	Hold	150	–	–	﹤0.01%	2822
2020 Q2	$384	Hold	150	–	–	﹤0.01%	2778
2020 Q1	$434	Hold	150	–	–	﹤0.01%	2672
2019 Q4	$569	Hold	150	–	–	﹤0.01%	2739
2019 Q3	$767	Hold	150	–	–	﹤0.01%	2675
2019 Q2	$930	Hold	150	–	–	﹤0.01%	2595
2019 Q1	$1.07K	Hold	150	–	–	﹤0.01%	2475
2018 Q4	$1.28K	Hold	150	–	–	﹤0.01%	2223
2018 Q3	$3K	Hold	150	–	–	﹤0.01%	2148
2018 Q2	$3.88K	Hold	150	–	–	﹤0.01%	2062
2018 Q1	$3.58K	Buy	+150	New	+$4.73K	﹤0.01%	1980

American Portfolios Advisors's ADMS Position: Q4 2021 in Review

American Portfolios Advisors sold out of Adamas Pharmaceuticals (ADMS) in Q4 2021, closing a stake of 150 shares — an estimated $737 sold.

American Portfolios Advisors first reported a position in ADMS in Q1 2018 and held it in 15 quarters. The position peaked at $3.88K in Q2 2018. 0 funds tracked by Wall St. Rank hold ADMS as of Q4 2021.

American Portfolios Advisors reported no remaining Adamas Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
American Portfolios Advisors sold 150 Adamas Pharmaceuticals shares in Q4 2021, an estimated $737.
American Portfolios Advisors first reported a position in Adamas Pharmaceuticals in Q1 2018 and held it in 15 quarters.
American Portfolios Advisors's Adamas Pharmaceuticals position peaked at $3.88K in Q2 2018.
0 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q4 2021.

Based on American Portfolios Advisors's 13F filing for Q4 2021, filed 21 Mar 2023.